![Andreas Grauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Grauer
Hoofd Techniek/Wetenschap/O&O bij
SAGIMET BIOSCIENCES INC.
Vermogen: - $ op 31-05-2026
Profiel
Andreas Grauer currently works at Federation Bio, Inc., as Chief Medical Officer from 2021 and Sagimet Biosciences, Inc., as Chief Medical Officer from 2026.
Dr. Grauer also formerly worked at Procter & Gamble Pharmaceuticals, Inc., as Global Executive Medical Director from 2000 to 2007, Corcept Therapeutics, Inc., as Chief Medical Officer from 2019 to 2021, Amgen, Inc., as Vice President-Global Development, and Omeros Corp., as Chief Medical Officer & Vice President.
Dr. Grauer received his doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-05-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Andreas Grauer
| Bedrijven | Functie | Begin |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Hoofd Techniek/Wetenschap/O&O | 20-04-2026 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Hoofd Techniek/Wetenschap/O&O | 01-10-2021 |
Eerdere bekende functies van Andreas Grauer
| Bedrijven | Functie | Einde |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 10-08-2021 |
| AMGEN INC. | Corporate Officer/Principal | 01-12-2018 |
Procter & Gamble Pharmaceuticals, Inc.
 Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 |
| OMEROS CORPORATION | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Andreas Grauer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Health Technology |
Kies MarketScreener 
